Additionally, a new family of proteins named Schlafen (SLFN) was acknowledged for being crucial for hPARP activity, especially SLFN-11, and was found to be a predictive biomarker for hPARP inhibitor-sensitive cancer types [25,26]. Here, SLFN11 is linked to cancer.